The a2 Milk Company chief executive David Bortolussi is mulling acquisitions in China and New Zealand to help gain faster access to a wider range of Chinese label infant nutrition formulations for the largest infant formula market in the world.
A2 Milk’s most critical business development focus is to ensure it delivers its full potential in the China infant formula market, valued in the region at $26 billion. It is the group’s largest sales and earnings generator.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
